Navigation Links
Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
Date:3/19/2013

NEW YORK, March 19, 2013 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI), concerning whether the board has breached its fiduciary duties to shareholders.

(Logo:  http://photos.prnewswire.com/prnh/20120215/MM54604LOGO )

On March 12, 2013, the Company announced that sales of its drug, FUSILEV, would be significantly lower during 2013 due to changes in market demand for FUSILEV.  As a result, the Company decreased its 2013 revenue guidance from approximately $300 million to as low as $160 million.On this news, Spectrum shares lost more than 35% of their value in one day of trading to close at $7.79 per share on March 13, 2013, down from $12.43 per share at close on March 12, 2013.

Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.

If you own Spectrum shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:Robert I. Harwood, Esq.Matthew M. Houston, Esq.Benjamin I. Sachs-Michaels, Esq.Harwood Feffer LLP488 Madison AvenueNew York, New York 10022Phone Numbers:

(877) 935-7400(212)935-7400Email:  bsachsmichaels@hfesq.comWebsite:
http://www.hfesq.com Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising. © 2013 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

 


'/>"/>
SOURCE Harwood Feffer LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Harwood Feffer LLP Announces Investigation of MAP Pharmaceuticals, Inc.
2. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
3. Harwood Feffer LLP Announces Investigation of PSS World Medical, Inc.
4. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
5. EGEN, Inc. Announces a Phase I Clinical Trial for Advanced Ovarian Cancer
6. National Minority Quality Forum Announces Support for Government Noninterference in Drug Price Negotiations
7. MGC Diagnostics Corporation Announces Worldwide Exclusive Distribution Partnership with Restech Respiratory Technology
8. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
9. BioElectronics Announces Chronic and Postoperative Wound Care Product Distribution in Italy
10. Athena Diagnostics Announces New Genetic Testing Services for Rare Neurological Disorders
11. Precision Optics Corporation Announces Reciept Of $660,000 Purchase Order For Custom-Designed Endoscopes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Call and Webcast to Follow Vanda Pharmaceuticals Inc. (Vanda) ... for the fourth quarter of 2016 on Wednesday, February 15, 2017, ... ... ET on Wednesday, February 15, 2017, during which management will discuss ... corporate activities. To participate in the conference call, please dial 1-888-771-4371 ...
(Date:1/19/2017)... , Jan. 19, 2017  Stealth BioTherapeutics Inc. ... to treat mitochondrial dysfunction, today announced new additions to ... M.D., as Chief Medical Officer, and Daniel Geffken ... announced that Jim Carr , Pharm.D. has been ... "We are pleased to welcome Doug and Daniel to ...
(Date:1/19/2017)... CITY, Calif. , Jan. 19, 2017  Abaxis, ... company manufacturing point-of-care blood analysis instruments and consumables for ... conference call to discuss its financial results for the ... The call will be at 4:15 p.m. ET on ... results for the third quarter fiscal year 2017 after ...
Breaking Medicine Technology:
(Date:1/21/2017)... ... 21, 2017 , ... Salveo for life, a company that distributes an effervescent ... United States as part of its presence to expand its market reach. , Using ... the productions of nasty toxins as a result of drinking alcohol, eliminating those toxins ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Phytocéane ... Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. Inspired ... Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this ...
(Date:1/21/2017)... ... January 21, 2017 , ... Santa Rosa Orthopaedics (SRO) ... located at 167 Lynch Creek Way. The Petaluma office features three comfortable patient ... and rehabilitation services and on-site x-ray services. Two multi-specialist orthopaedic surgeons Dr. ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Spectrum Aquatics Launches New ADA Portable Motion Trek ... space. Since the lift is mounted on wheels, it can be wheeled out of the ... kit, to fasten to the deck. "We have transformed the feedback from customers into specific ...
(Date:1/20/2017)... Raton, FL (PRWEB) , ... January 20, 2017 , ... ... seaweeds, botanicals and 100 percent pure essential oils, announced the company had a successful ... SC. , The annual ECRM event gives companies that work in the nutritional, sports ...
Breaking Medicine News(10 mins):